In 2020, more than 2.7 million people were diagnosed with cancer in the European Union (EU), whereas 1.3 million people died from cancer. By 2035, the number of cancer cases is expected to increase by 24%, making cancer the leading cause of death in the EU. Currently, the leading specific molecular imaging technique for cancer diagnosis is based on positron emission tomography (PET), which is available in less than 0.5% of medical centers worldwide, mainly due to the high cost of PET scanners. In the European Innovation Council project PetVision, coordinated by the Jožef Stefan Institute, we are developing a new generation of devices that will enable completely modular, affordable, and adaptable PET scanners by means of precise time measurement. In this lecture, I will present the long-term vision, project goals and breakthroughs in the design of the detector, photosensor and data acquisition electronics.
Dose assessment: from conceptual model to environmental radioactivity monitoring
Radionuclides are discharged into the environment from a variety of nuclear and radiation facilities, potentially causing harmful effects on human health and the environment. If discharges are likely to result in adverse radiological effects, they must be evaluated in...
